Robert Joseph Toth Jr is Director of Kintara Therapeutics, Inc.. Currently has a direct ownership of 1,566 shares of KTRA, which is worth approximately $281. The most recent transaction as insider was on Apr 29, 2021, when has been sold 325 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.57K
0% 3M change
0% 12M change
Total Value Held $281

ROBERT JOSEPH TOTH Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 29 2021
BUY
Conversion of derivative security
-
325 Added 17.19%
1,566 Common Stock
Apr 29 2021
BUY
Other acquisition or disposition
-
3 Added 0.24%
1,241 Common Stock
Mar 31 2021
BUY
Other acquisition or disposition
-
8 Added 0.64%
1,238 Common Stock
Dec 31 2020
BUY
Other acquisition or disposition
-
8 Added 0.65%
1,230 Common Stock
Sep 30 2020
BUY
Other acquisition or disposition
-
8 Added 0.65%
1,222 Common Stock
RJT

Robert Joseph Toth Jr

Director
San Diego, CA

Track Institutional and Insider Activities on KTRA

Follow Kintara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KTRA shares.

Notify only if

Insider Trading

Get notified when an Kintara Therapeutics, Inc. insider buys or sells KTRA shares.

Notify only if

News

Receive news related to Kintara Therapeutics, Inc.

Track Activities on KTRA